These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Improving care to patients with ischemic heart disease: experiences in a single network of the Veterans Health Administration. Pineros SL; Sales AE; Li YF; Sharp ND Worldviews Evid Based Nurs; 2004; 1 Suppl 1():S33-40. PubMed ID: 17129333 [TBL] [Abstract][Full Text] [Related]
9. Achieving cholesterol target in a managed care organization (ACTION) trial. Straka RJ; Taheri R; Cooper SL; Smith JC Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283 [TBL] [Abstract][Full Text] [Related]
10. Lipid control in patients with coronary heart disease treated in primary care or cardiology clinics. Pereg D; Elis A; Neuman Y; Mosseri M; Leader A; Segev D; Granek-Catarivas M; Lishner M; Hermoni D J Clin Lipidol; 2013; 7(6):637-41. PubMed ID: 24314362 [TBL] [Abstract][Full Text] [Related]
11. Ambulatory hypercholesterolemia management in patients with atherosclerosis. Gender and race differences in processes and outcomes. Persell SD; Maviglia SM; Bates DW; Ayanian JZ J Gen Intern Med; 2005 Feb; 20(2):123-30. PubMed ID: 15836544 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study. Lee KK; Lee VW; Chan WK; Lee BS; Chong AC; Wong JC; Yin D; Alemao E; Tomlinson B Value Health; 2008 Mar; 11 Suppl 1():S91-8. PubMed ID: 18387073 [TBL] [Abstract][Full Text] [Related]
13. Degree of Lipid Control in Patients With Coronary Heart Disease and Measures Adopted by Physicians. REPAR Study. Galve E; Cordero A; Cequier A; Ruiz E; González-Juanatey JR Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):931-938. PubMed ID: 27178117 [TBL] [Abstract][Full Text] [Related]
14. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy. Allison TG; Squires RW; Johnson BD; Gau GT Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076 [TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic. Kiburg KV; Ward GM; O'Neal DN; MacIsaac RJ Intern Med J; 2018 Feb; 48(2):201-204. PubMed ID: 29415350 [TBL] [Abstract][Full Text] [Related]
17. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study. Swislocki AL; Lin K; Cogburn D; Fann KY; Khuu DT; Noth RH Am J Manag Care; 1997 Oct; 3(10):1537-45. PubMed ID: 10178460 [TBL] [Abstract][Full Text] [Related]
18. Management of high blood cholesterol by primary care physicians: diffusion of the National Cholesterol Education Program Adult Treatment Panel guidelines. Shea S; Gemson DH; Mossel P J Gen Intern Med; 1990; 5(4):327-34. PubMed ID: 2374043 [TBL] [Abstract][Full Text] [Related]
19. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Gylling H; Miettinen TA Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225 [TBL] [Abstract][Full Text] [Related]
20. [Are high levels of HDL always associated with a reduced risk of myocardial infarction? - lipid therapy should still focus on lowering LDL cholesterol levels]. Laufs U Dtsch Med Wochenschr; 2012 Oct; 137(43):2200. PubMed ID: 23076665 [No Abstract] [Full Text] [Related] [Next] [New Search]